UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Trimmed by PCG Wealth Advisors LLC

PCG Wealth Advisors LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 19.5% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 462 shares of the healthcare conglomerate’s stock after selling 112 shares during the quarter. PCG Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $237,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Advocacy Wealth Management Services LLC grew its stake in shares of UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. grew its stake in shares of UnitedHealth Group by 100.0% in the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 30 shares during the last quarter. Evolution Advisers Inc. acquired a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $38,000. Rise Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $38,000. Finally, Cordant Inc. acquired a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $45,000. 87.25% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on UNH. Raymond James lifted their target price on shares of UnitedHealth Group from $620.00 to $635.00 in a research report on Thursday. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $570.00 to $587.00 in a research report on Monday, July 18th. Oppenheimer lifted their target price on shares of UnitedHealth Group from $600.00 to $610.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. BMO Capital Markets lifted their target price on shares of UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. Finally, Sanford C. Bernstein cut shares of UnitedHealth Group from an “outperform” rating to a “market perform” rating and set a $561.00 target price for the company. in a research note on Thursday, May 26th. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $586.40.

Insider Activity at UnitedHealth Group

In related news, CEO Andrew Witty sold 11,376 shares of the stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the sale, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CEO Andrew Witty sold 11,376 shares of the stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the completion of the sale, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Stephen J. Hemsley sold 99,312 shares of the stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $534.27, for a total value of $53,059,422.24. Following the sale, the director now directly owns 787,372 shares of the company’s stock, valued at $420,669,238.44. The disclosure for this sale can be found here. Insiders have sold 139,051 shares of company stock worth $74,450,958 in the last ninety days. Company insiders own 0.40% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $517.46 on Friday. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 0.60. UnitedHealth Group Incorporated has a 1 year low of $383.12 and a 1 year high of $553.29. The company has a market cap of $484.02 billion, a PE ratio of 27.02, a PEG ratio of 1.61 and a beta of 0.76. The company’s 50-day moving average is $530.11 and its two-hundred day moving average is $512.45.

UnitedHealth Group (NYSE:UNHGet Rating) last released its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. The company had revenue of $80.33 billion for the quarter, compared to the consensus estimate of $79.68 billion. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The company’s revenue was up 12.6% compared to the same quarter last year. During the same period in the prior year, the company posted $4.70 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 21.85 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Monday, September 12th were given a $1.65 dividend. The ex-dividend date was Friday, September 9th. This represents a $6.60 dividend on an annualized basis and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio is 34.46%.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.